Recombinant Anti-malaria antigen x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) (SCTB-102)

Recombinant Anti-malaria antigen x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) is designed to be expressed as a single chain with three scFv units, two distal binding sites for malaria antigen and a central site for CD89 . It contains a His-tag at the C/N terminus for affinity purification. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

malaria antigen & CD89

Type

Single-chain Triplebody

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Target 2

CD89

Gene ID

2204

UniProt ID

P24071

Alternative Names

FcαRI; FCAR; Fc fragment of IgA, receptor for; CD89; FcalphaRI; immunoglobulin alpha Fc receptor; Fc alpha receptor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

See other bsAb targets related to "CD89"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-malaria antigen x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) (SCTB-102). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-malaria antigen x Anti-CD89 Bispecific Antibody (Single-chain Triplebody) (CAT#: SCTB-102)

Specifications

Targets

Customer Reviews and Q&As